Literature DB >> 24130124

Subtle gait changes in patients with REM sleep behavior disorder.

Eric M McDade1, Brendon P Boot, Teresa J H Christianson, V Shane Pankratz, Bradley F Boeve, Tanis J Ferman, Kevin Bieniek, John H Hollman, Rosebud O Roberts, Michelle M Mielke, David S Knopman, Ronald C Petersen.   

Abstract

Many people with rapid eye movement (REM) sleep behavior disorder (RBD) have an underlying synucleinopathy, the most common of which is Lewy body disease. Identifying additional abnormal clinical features may help in identifying those at greater risk of evolving to a more severe syndrome. Because gait disorders are common in the synucleinopathies, early abnormalities in gait in those with RBD could help in identifying those at increased risk of developing overt parkinsonism and/or cognitive impairment. We identified 42 probable RBD subjects and 492 controls using the Mayo Sleep Questionnaire and assessed gait velocity, cadence, and stride dynamics with an automated gait analysis system. Cases and controls were similar in age (79.9 ± 4.7 and 80.1 ± 4.7, P = 0.74), Unified Parkinson's Disease Rating Scale Part III (UPDRS) score (3.3 ± 5.5 and 1.9 ± 4.1, P = 0.21) and Mini-Mental State Examination scores (27.2 ± 1.9 and 27.7 ± 1.6, P = 0.10). A diagnosis of probable RBD was associated with decreased velocity (-7.9 cm/s; 95% confidence interval [CI], -13.8 to -2.0; P < 0.01), cadence (-4.4 steps/min; 95% CI, -7.6 to -1.3; P < 0.01), significantly increased double limb support variability (30%; 95% CI, 6-60; P = 0.01), and greater stride time variability (29%; 95% CI, 2-63; P = 0.03) and swing time variability (46%; 95% CI, 15-84; P < 0.01). Probable RBD is associated with subtle gait changes prior to overt clinical parkinsonism. Diagnosis of probable RBD supplemented by gait analysis may help as a screening tool for disorders of α-synuclein.
© 2013 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  REM sleep behavior disorder; gait; gait variability

Mesh:

Year:  2013        PMID: 24130124      PMCID: PMC3952497          DOI: 10.1002/mds.25653

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  32 in total

1.  Quantitative gait dysfunction and risk of cognitive decline and dementia.

Authors:  Joe Verghese; Cuiling Wang; Richard B Lipton; Roee Holtzer; Xiaonan Xue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-19       Impact factor: 10.154

2.  A common cognitive profile in elderly fallers and in patients with Parkinson's disease: the prominence of impaired executive function and attention.

Authors:  Jeffrey M Hausdorff; Glen M Doniger; Shmuel Springer; Galit Yogev; Ely S Simon; Nir Giladi
Journal:  Exp Aging Res       Date:  2006 Oct-Dec       Impact factor: 1.645

3.  Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease.

Authors:  M U Ferraye; B Debû; V Fraix; L Goetz; C Ardouin; J Yelnik; C Henry-Lagrange; E Seigneuret; B Piallat; P Krack; J-F Le Bas; A-L Benabid; S Chabardès; P Pollak
Journal:  Brain       Date:  2009-09-22       Impact factor: 13.501

Review 4.  Substrates for normal gait and pathophysiology of gait disturbances with respect to the basal ganglia dysfunction.

Authors:  Kaoru Takakusaki; Nozomi Tomita; Masafumi Yano
Journal:  J Neurol       Date:  2008-08       Impact factor: 4.849

5.  REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features.

Authors:  R B Postuma; J F Gagnon; M Vendette; K Charland; J Montplaisir
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-08-05       Impact factor: 10.154

6.  Gait dysfunction in mild cognitive impairment syndromes.

Authors:  Joe Verghese; Matthew Robbins; Roee Holtzer; Molly Zimmerman; Cuiling Wang; Xiaonan Xue; Richard B Lipton
Journal:  J Am Geriatr Soc       Date:  2008-05-14       Impact factor: 5.562

7.  Dual-task decrements in gait: contributing factors among healthy older adults.

Authors:  Jeffrey M Hausdorff; Avraham Schweiger; Talia Herman; Galit Yogev-Seligmann; Nir Giladi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-12       Impact factor: 6.053

8.  Executive functions are associated with gait and balance in community-living elderly people.

Authors:  Marianne B van Iersel; Roy P C Kessels; Bastiaan R Bloem; André L M Verbeek; Marcel G M Olde Rikkert
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-12       Impact factor: 6.053

9.  Test-retest reliability of spatial and temporal gait parameters of people with Alzheimer's disease.

Authors:  Joanne E Wittwer; Kate E Webster; Peta T Andrews; Hylton B Menz
Journal:  Gait Posture       Date:  2008-03-05       Impact factor: 2.840

Review 10.  The role of executive function and attention in gait.

Authors:  Galit Yogev-Seligmann; Jeffrey M Hausdorff; Nir Giladi
Journal:  Mov Disord       Date:  2008-02-15       Impact factor: 10.338

View more
  17 in total

Review 1.  Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.

Authors:  Birgit Högl; Ambra Stefani; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2017-11-24       Impact factor: 42.937

Review 2.  Parkinson's disease and sleep/wake disturbances.

Authors:  Keisuke Suzuki; Masayuki Miyamoto; Tomoyuki Miyamoto; Koichi Hirata
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

3.  Preface for the 3rd Clinical Update Sleep, 23rd February 2018, Royal College of Physicians, London, UK: year in review.

Authors:  Culadeeban Ratneswaran; Manpreet K Sagoo; Joerg Steier
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

4.  Neurological update: emerging issues in gait disorders.

Authors:  Simon J G Lewis
Journal:  J Neurol       Date:  2015-03-04       Impact factor: 4.849

5.  Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: A harbinger of freezing of gait?

Authors:  Laila Alibiglou; Aleksandar Videnovic; Peggy J Planetta; David E Vaillancourt; Colum D MacKinnon
Journal:  Mov Disord       Date:  2016-06-02       Impact factor: 10.338

6.  Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity.

Authors:  Emily J Hill; C Grant Mangleburg; Isabel Alfradique-Dunham; Brittany Ripperger; Amanda Stillwell; Hiba Saade; Sindhu Rao; Oluwafunmiso Fagbongbe; Rainer von Coelln; Arjun Tarakad; Christine Hunter; Robert J Dawe; Joseph Jankovic; Lisa M Shulman; Aron S Buchman; Joshua M Shulman
Journal:  Parkinsonism Relat Disord       Date:  2021-02-10       Impact factor: 4.891

Review 7.  Motor Dysfunction in REM Sleep Behavior Disorder: A Rehabilitation Framework for Prodromal Synucleinopathy.

Authors:  Rebekah L S Summers; Miriam R Rafferty; Michael J Howell; Colum D MacKinnon
Journal:  Neurorehabil Neural Repair       Date:  2021-05-12       Impact factor: 3.919

8.  REM Sleep Without Atonia and Gait Impairment in People with Mild-to-Moderate Parkinson's Disease.

Authors:  Sommer L Amundsen-Huffmaster; Matthew N Petrucci; Maria E Linn-Evans; Jae Woo Chung; Michael J Howell; Aleksandar Videnovic; Paul J Tuite; Scott E Cooper; Colum D MacKinnon
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

Review 9.  Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson's Disease and Other Synucleinopathies.

Authors:  Matej Skorvanek; Eva Feketeova; Monica M Kurtis; Jan Rusz; Karel Sonka
Journal:  Front Neurol       Date:  2018-05-25       Impact factor: 4.003

10.  Brainstem Quadruple Aberrant Hyperphosphorylated Tau, Beta-Amyloid, Alpha-Synuclein and TDP-43 Pathology, Stress and Sleep Behavior Disorders.

Authors:  Lilian Calderón-Garcidueñas; Ravi Philip Rajkumar; Elijah W Stommel; Randy Kulesza; Yusra Mansour; Adriana Rico-Villanueva; Jorge Orlando Flores-Vázquez; Rafael Brito-Aguilar; Silvia Ramírez-Sánchez; Griselda García-Alonso; Diana A Chávez-Franco; Samuel C Luévano-Castro; Edgar García-Rojas; Paula Revueltas-Ficachi; Rodolfo Villarreal-Ríos; Partha S Mukherjee
Journal:  Int J Environ Res Public Health       Date:  2021-06-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.